O11. The results of gefitinib in front line treatment of Caucasian patients with NSCLC in the Czech Republic: analysis according to activated mutations location

BACKGROUND: This study evaluates treatment outcomes in 127 non-small cell lung cancer (NSCLC) patients from Czech Republic according to activated mutations located in exons 19 (Del19) and 21 (L858R). METHODS: NSCLC patients with epidermal growth factor receptor (EGFR) activated mutations were treate...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Transl Lung Cancer Res
Egile Nagusiak: Skrickova, Jana, Bortlicek, Zbynek, Hejduk, Karel, Pesek, Milos, Kolek, Vitezslav, Koubkova, Leona, Tomiskova, Marcela, Roubec, Jaromir, Havel, Libor, Salajka, Frantisek
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Pioneer Bioscience Publishing Company 2014
Gaiak:
CELCC 2014 Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367746/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB010
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak